GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Creo Medical Group PLC (LSE:CREO) » Definitions » Cash Flow from Discontinued Operations

Creo Medical Group (LSE:CREO) Cash Flow from Discontinued Operations : £0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Creo Medical Group Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Creo Medical Group's cash flow from discontinued operations for the six months ended in Dec. 2023 was £0.00 Mil. It means Creo Medical Group received £0.00 Mil from the sale of part of business quarterly. Creo Medical Group's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Dec. 2023 was £0.00 Mil.

Creo Medical Group Cash Flow from Discontinued Operations Historical Data

The historical data trend for Creo Medical Group's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creo Medical Group Cash Flow from Discontinued Operations Chart

Creo Medical Group Annual Data
Trend Feb14 Feb15 Feb16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial Premium Member Only - - - - -

Creo Medical Group Semi-Annual Data
Feb14 Feb15 Feb16 Dec16 Jun17 Dec17 Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Creo Medical Group Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creo Medical Group Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Creo Medical Group's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Creo Medical Group (LSE:CREO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Creo Medical Group PLC (LSE:CREO) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
LSE:EKF LSE:BELL LSE:IUG LSE:IHC LSE:POLX LSE:SUN LSE:MHC LSE:DEMG LSE:RUA LSE:MXCT ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH
Website
https://www.creomedical.com
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy.

Creo Medical Group (LSE:CREO) Headlines

No Headlines